Yuka Harada

3.3k total citations
106 papers, 2.0k citations indexed

About

Yuka Harada is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Yuka Harada has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 35 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Yuka Harada's work include Acute Myeloid Leukemia Research (45 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Yuka Harada is often cited by papers focused on Acute Myeloid Leukemia Research (45 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Yuka Harada collaborates with scholars based in Japan, United States and Kazakhstan. Yuka Harada's co-authors include Hironori Harada, Toshiya Inaba, Akiro Kimura, Hiromasa Niimi, Taiichi Kyo, Toshio Kitamura, Jiro Kitaura, N Huang, Hideo Tanaka and Yukiko Komeno and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuka Harada

99 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuka Harada Japan 23 1.2k 1.0k 493 267 229 106 2.0k
Motoshi Ichikawa Japan 25 1.1k 0.9× 1.3k 1.3× 373 0.8× 634 2.4× 210 0.9× 102 2.6k
Francesco Albano Italy 25 1.0k 0.8× 771 0.8× 597 1.2× 161 0.6× 279 1.2× 140 1.8k
Rakash Nayar Canada 10 1.1k 0.9× 489 0.5× 426 0.9× 434 1.6× 131 0.6× 13 1.8k
Saskia Langemeijer Netherlands 16 877 0.7× 976 1.0× 445 0.9× 578 2.2× 164 0.7× 51 1.9k
Serge Fichelson France 29 1.1k 0.9× 1.2k 1.2× 522 1.1× 482 1.8× 148 0.6× 65 2.5k
Barbara Czepulkowski United Kingdom 19 789 0.6× 556 0.5× 274 0.6× 277 1.0× 142 0.6× 49 1.7k
Kazutaka Kuriyama Japan 23 1.8k 1.4× 1.1k 1.1× 540 1.1× 265 1.0× 125 0.5× 61 2.3k
Aiko Sato‐Otsubo Japan 20 494 0.4× 860 0.8× 231 0.5× 352 1.3× 295 1.3× 40 1.6k
Gerlinde Mitterbauer Austria 27 1.1k 0.9× 645 0.6× 404 0.8× 428 1.6× 98 0.4× 57 1.8k
A. Hagemeijer Netherlands 24 820 0.7× 843 0.8× 339 0.7× 272 1.0× 123 0.5× 53 1.9k

Countries citing papers authored by Yuka Harada

Since Specialization
Citations

This map shows the geographic impact of Yuka Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Harada more than expected).

Fields of papers citing papers by Yuka Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Harada. The network helps show where Yuka Harada may publish in the future.

Co-authorship network of co-authors of Yuka Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Harada. A scholar is included among the top collaborators of Yuka Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Harada. Yuka Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Toya, Takashi, et al.. (2025). Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients. International Journal of Hematology. 121(6). 820–832.
3.
Hayashi, Yoshihiro, Rika Iwata, Kanako Yuki, et al.. (2024). IL36G-producing neutrophil-like monocytes promote cachexia in cancer. Nature Communications. 15(1). 7662–7662. 6 indexed citations
4.
Katagiri, Seiichiro, Daigo Akahane, Yosuke Minami, et al.. (2023). Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy. OncoTargets and Therapy. Volume 16. 571–576. 1 indexed citations
5.
Kurosawa, Shuhei, Takashi Toya, Tsunekazu Hishima, et al.. (2021). Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing. SHILAP Revista de lepidopterología. 2(4). 854–860. 2 indexed citations
6.
Yokomizo‐Nakano, Takako, Sho Kubota, Jie Bai, et al.. (2020). Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome. Cancer Research. 80(12). 2523–2536. 14 indexed citations
7.
Najima, Yuho, Yuka Harada, Keisuke Oboki, et al.. (2020). Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT. Bone Marrow Transplantation. 56(2). 334–346. 12 indexed citations
8.
Uchida, Tomoyuki, Jiro Kitaura, Fumio Nakahara, et al.. (2014). Hes1 upregulation contributes to the development of FIP1L1-PDGRA–positive leukemia in blast crisis. Experimental Hematology. 42(5). 369–379.e3. 6 indexed citations
9.
Imagawa, Jun, Hideo Tanaka, Kana Matsumoto, et al.. (2012). A sharp fluctuation in peripheral blood cells shortly after dasatinib administration. International Journal of Hematology. 96(2). 194–199. 6 indexed citations
10.
Oki, Toshihiko, Jiro Kitaura, Naoko Watanabe‐Okochi, et al.. (2011). Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. Leukemia. 26(5). 1038–1045. 27 indexed citations
11.
Harada, Yuka & Hironori Harada. (2010). Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations. Journal of Cellular Biochemistry. 112(2). 425–432. 19 indexed citations
12.
Watanabe‐Okochi, Naoko, Jiro Kitaura, Ryoichi Ono, et al.. (2008). AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood. 111(8). 4297–4308. 115 indexed citations
13.
Harada, Hironori, Yuka Harada, Darin P. O’Brien, et al.. (1999). HERF1, a Novel Hematopoiesis-Specific RING Finger Protein, Is Required for Terminal Differentiation of Erythroid Cells. Molecular and Cellular Biology. 19(5). 3808–3815. 46 indexed citations
14.
Asahara, Hiroshi, Akira Kawai, Yuka Harada, Miki Senda, & H. Inoue. (1996). Spinal schwannomas: a review of 42 cases.. Okayama University Scientific Achievement Repository (Okayama University). 50(1). 25–8. 22 indexed citations
15.
Harada, Yuka, Michio Kawano, N Huang, et al.. (1996). Identification of early plasma cells in peripheral blood and their clinical significance. British Journal of Haematology. 92(1). 184–191. 93 indexed citations
16.
Asou, Hiroya, Hideki Asaoku, Koji Iwato, et al.. (1995). A specific chromosome abnormality of t(4;12)(qll‐12;pl3) in CD7+ acute leukaemia. British Journal of Haematology. 90(4). 850–854. 10 indexed citations
17.
Kondo, Takashi, et al.. (1993). Some Properties of Garlic Mosaic Virus (GMV) and Garlic Latent Virus (GLV) Isolated from Garlic Plants with Mosaic Symptoms in Aomori Prefecture. 59(1). 57. 1 indexed citations
18.
Harada, Yuka, et al.. (1984). CB18 DISCRIMINATION OF FOOD IN PARAMECIUM MULTIMICRONUCLEATUM.(Cell Biology)(Proceedings of the Fifty-Fifth Annual Meeting of the Zoological Society of Japan) :. ZOOLOGICAL SCIENCE. 1(6). 889. 1 indexed citations
19.
Harada, Yuka, et al.. (1971). A Survey on Swine Toxoplasmosis in Meat Inspection by the Immunofluorescent Test. Journal of the Japan Veterinary Medical Association. 24(12). 679–684. 1 indexed citations
20.
Akahane, Hiroshige, et al.. (1968). Patterns of the variation of Fasciola sp. in Japan. II. A comparative study of the flukes from cattle and goat.. Kiseichūgaku zasshi. 17(6). 534–539. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoshi Ichikawa Breakdown of academic impact, for papers by Francesco Albano Breakdown of academic impact, for papers by Rakash Nayar Breakdown of academic impact, for papers by Saskia Langemeijer Breakdown of academic impact, for papers by Serge Fichelson Breakdown of academic impact, for papers by Barbara Czepulkowski Breakdown of academic impact, for papers by Kazutaka Kuriyama Breakdown of academic impact, for papers by Aiko Sato‐Otsubo Breakdown of academic impact, for papers by Gerlinde Mitterbauer Breakdown of academic impact, for papers by A. Hagemeijer
Rankless by CCL
2026